Tomohiko Ishikawa
3PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 30, 2021
Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout.Tomohiko Ishikawa, Toshinari Takahashi, Tetsuya Taniguchi
|Jul 05, 2020
Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study.Tomohiko Ishikawa, Tatsushi Maeda, Teruo Hashimoto
|Sep 17, 2018
Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout.Tatsuo Hosoya, Tomohiko Ishikawa, Yoshimi Ogawa
Pageof 1
